Table III.
Top ten differentially expressed lncRNAs for each comparison.
| Gene symbol | P-value | Fold-change | Regulation |
|---|---|---|---|
| C vs. N | |||
| lnc-FADD-2 | 3.54×10−6 | 374.60214 | Upregulated |
| lnc-TERT-2 | 1.77×10−5 | 326.4259 | Upregulated |
| lnc-LPP-2 | 9.15×10−6 | 227.83163 | Downregulated |
| lnc-PHLDA3-3 | 1.38×10−5 | 213.00255 | Downregulated |
| lnc-GPR108-2 | 3.20×10−4 | 99.080215 | Downregulated |
| lnc-DIRC3-4 | 1.65×10−5 | 91.854065 | Downregulated |
| lnc-C3orf80-3 | 5.60×10−6 | 79.911095 | Upregulated |
| lnc-C11orf89-3 | 7.06×10−5 | 77.44088 | Upregulated |
| lnc-CFH-2 | 2.51×10−4 | 74.221596 | Upregulated |
| lnc-CFHR3-1 | 1.31×10−5 | 71.0337 | Upregulated |
| C vs. Y | |||
| lnc-TERT-2 | 5.72×10−5 | 169.64801 | Upregulated |
| lnc-OMD-1 | 7.32×10−4 | 95.35182 | Upregulated |
| lnc-ATP7A-2 | 7.29×10−6 | 31.169392 | Upregulated |
| lnc-TCF4-6 | 2.13×10−3 | 23.001923 | Downregulated |
| lnc-RERE-4 | 6.76×10−4 | 21.957548 | Upregulated |
| lnc-TCP1-5 | 3.99×10−3 | 20.307957 | Upregulated |
| lnc-SNRPN-2//RP11-701H24.7//NONHSAG016304 | 2.28×10−2 | 18.521355 | Downregulated |
| lnc-FAM108B1-3 | 7.44×10−4 | 17.824202 | Upregulated |
| lnc-C15orf54-4//CTD-2033D15.2//NONHSAG016560 | 1.04 ×10−2 | 15.087145 | Upregulated |
| lnc-ATP7A-1 | 2.44×10−4 | 14.85991 | Upregulated |
| Y vs. N | |||
| lnc-SIDT2-1 | 4.30×10−4 | 610.91364 | Downregulated |
| lnc-FADD-2 | 2.85×10−6 | 597.95306 | Upregulated |
| lnc-RP1-177G6.2.1–2 | 1.50×10−7 | 522.8559 | Downregulated |
| lnc-DYNC2LI1-1 | 1.60×10−6 | 469.5526 | Upregulated |
| CDR1-AS//lnc-RP1-177G6.2.1–3//NONHSAG055442 | 1.89×10−11 | 196.92441 | Downregulated |
| lnc-LPP-2 | 3.19×10−5 | 175.79048 | Downregulated |
| lnc-C11orf89-3 | 2.42×10−5 | 146.4682 | Upregulated |
| lnc-RPH3AL-2 | 2.29×10−4 | 146.42218 | Upregulated |
| lnc-CFH-2 | 4.91×10−5 | 116.60803 | Upregulated |
| lnc-SLC27A6-3 | 2.86×10−5 | 104.92543 | Upregulated |
lncRNA, long non-coding RNA; N, normal gastric tissue samples; Y, primary gastrointestinal stromal tumor samples; C, imatinib mesylate-resistant gastrointestinal stromal tumor samples.